Results for tag: "Temsirolimus"

Temsirolimus is a drug used to treat advanced skin cancer. It is an mTOR inhibitor, meaning it works by blocking the activity of a protein that helps cancer cells grow and divide. It is used in combination with other drugs to treat advanced melanoma, a type of skin cancer. Temsirolimus is administered intravenously and is usually given once a week. Common side effects include fatigue, nausea, and diarrhea. Temsirolimus is a relatively new drug and is not yet widely available. It is approved for use in the United States, Europe, and other countries. It is also being studied in clinical trials for other types of cancer, such as breast cancer and renal cell carcinoma. The Temsirolimus market is growing as more people are diagnosed with skin cancer and the need for effective treatments increases. It is expected to continue to grow as more research is conducted and more countries approve its use. Some companies in the Temsirolimus market include Pfizer, Merck, and Novartis. Show Less Read more